Professor Nagy Habib

Professor Nagy Habib

All Publications

Journals

  • Sommerville CAM; Limongelli P; Pai M; Ahmad R; Stamp G; Habib NA; Williamson RCN; Jiao LR. (15 Dec 2009). Survival Analysis After Pancreatic Resection for Ampullary and Pancreatic Head Carcinoma: An Analysis of Clinicopathological Factors. J SURG ONCOL. 100:651-656. DOI.
  • Jiao LR; Apostolopoulos C; Jacob J; Szydlo R; Johnson N; Tsim N; Habib NA; Coombes RC; et al. (20 Dec 2009). Unique localization of circulating tumor cells in patients with hepatic metastases. J Clin Oncol. 27:6160-6165. DOI.
  • Khorsandi SE; Kysela P; Valek V; Olufemi OMS; Lazar I; Prochazka V; Zacharoulis D; Rountas C; et al. (Jun 2009). Initial data on a novel endovascular radiofrequency catheter when used for arterial occlusion in liver cancer. EUR SURG. 41:104-108. DOI.
  • Aspinall RJ; Seery JP; Taylor-Robinson SD; Habib N. (15 Nov 1996). Comments on "arterialization of the portal vein in orthotopic and auxiliary liver transplantation". Transplantation. 62:1375-1376.
  • Khan SA; Carmichael PL; Taylor-Robinson SD; Habib N; Thomas HC. (Apr 2002). Evidence of an environmental cause for the rise in cholangiocarcinoma. GUT. 50:A54-A54.
  • Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine NR; Thomas HC. (May 2006). Analysis of p53 mutations for a mutational signature in human intrahepatic cholangiocarcinoma. Int J Oncol. 28:1269-1277.
  • Zacharoulis D; Khorsandi SE; Vavra P; Dostalik J; Navarra G; Nicholls JP; Jiao LR; Habib NA. (Jul 2009). Pilot study for a new bipolar radiofrequency ablation/aspirator device in the management of primary and secondary liver cancers. LIVER INT. 29:824-830. DOI.
  • Aloysius MM; Mc Kechnie AJ; Robins RA; Verma C; Eremin JM; Farzaneh F; Habib NA; Bhalla J; et al. (19 Mar 2009). Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs. J TRANSL MED. 7. DOI.
  • Vavra P; Dostalik J; Zacharoulis D; Khorsandi SE; Khan SA; Habib NA. (Feb 2009). Endoscopic radiofrequency ablation in colorectal cancer: initial clinical results of a new bipolar radiofrequency ablation device. Dis Colon Rectum. 52:355-358. DOI.
  • Jiao LR; Ayav A; Navarra G; Sommerville C; Pai M; Damrah O; Khorsandi S; Habib NA. (Nov 2008). Laparoscopic liver resection assisted by the laparoscopic Habib Sealer. SURGERY. 144:770-774. DOI.
  • El-Gendi AM; Khorsandi SE; Pai M; Zacharoulis D; Nicholls JP; Spalding DRC; Jiao LR; Habib NA. (2008). Repeat hepatic resection using a radiofrequency-assisted technique. DIGEST SURG. 25:293-299. DOI.
  • Limongelli P; Khorsandi SE; Pai M; Jackson JE; Tait P; Tierris J; Habib NA; Williamson RC; et al. (Oct 2008). Management of delayed postoperative hemorrhage after pancreaticoduodenectomy: a meta-analysis. Arch Surg. 143:1001-1007. DOI.
  • Mintz PJ; Habib NA; Jones JL; Giamas G; Lewis JS; Bowen RL; Coombes RC; Stebbing J. (15 Sep 2008). The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer. CANCER. 113:1489-1495. DOI.
  • Pai M; Navarra G; Ayav A; Sommerville C; Khorsandi SK; Damrah O; Jiao LR; Habib NA. (2008). Laparoscopic Habibtrade mark 4X: a bipolar radiofrequency device for bloodless laparoscopic liver resection. HPB (Oxford). 10:261-264. DOI.
  • Pai M; Jiao LR; Khorsandi S; Canelo R; Spalding DR; Habib NA. (2008). Liver resection with bipolar radiofrequency device: Habibtrade mark 4X. HPB (Oxford). 10:256-260. DOI.
  • Pai M; Zacharoulis D; Milicevic MN; Helmy S; Jiao LR; Levicar N; Tait P; Scott M; et al. (Aug 2008). Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 103:1952-1958. DOI.
  • Khorsandi SE; Limongelli P; Jackson JE; Tait P; Williamson RC; Habib NA; Jiao LR. (2008). Management of delayed arterial hemorrhage after pancreaticoduodenectomy. A case series. JOP. 9:172-178.
  • Jiao LR; Tysome JR; Navarra G; Habib NA. (2005). Liver resection in a patient with concomitant thoraco-abdominal and cerebral aneurysms. HPB (Oxford). 7:73-76. DOI.
  • Leviar N; Pai M; Habib NA; Tait P; Jiao LR; Marley SB; Davis J; Dazzi E; et al. (Feb 2008). Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34(+) cells in patients with chronic. CELL PROLIFERATION. 41:115-125.
  • Mikhail MA; M'Hamdi H; Welsh J; Levicar N; Marley SB; Nicholls JP; Habib NA; Louis LS; et al. (Apr 2008). High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum Reprod. 23:928-933. DOI.
  • Diao Y; Ma J; Xiao WD; Luo J; Li XY; Chu KW; Fung PW; Habib N; et al. (2007). Inhibition of angiogenesis and HCT-116 xenograft tumor growth in mice by kallistain. World J Gastroenterology. 13:4615-4619.
  • Harrop R; Drury N; Shingler W; Chikoti P; Redchenko I; Carroll MW; Kingsman SM; Naylor S; et al. (2007). Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces immune responses. Clinical Cancer Research. 13:4487-4494.
  • Limongelli P; Pai M; Bansi D; Thiallinagram A; Tait P; Jackson J; Habib NA; Williamson RC; et al. (Sep 2007). Correlation between preoperative biliary drainage, bile duct contamination, and postoperative outcomes for pancreatic surgery. Surgery. 142:313-318. DOI.
  • Ayav A; Navarra G; Basaglia E; Tierris J; Healey A; Spalding D; Canelo R; Habib NA; et al. (Apr 2007). Results of major hepatectomy without vascular clamping using radiofrequency-assisted technique compared with total vascular exclusion. HEPATO-GASTROENTEROL. 54:806-809.
  • Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; et al. (Jun 2007). Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours. Eur J Surg Oncol. 33:597-602. DOI.
  • Guinn BA; Kasahara N; Farzaneh F; Habib NA; Norris JS; Deisseroth AB. (Jun 2007). Recent advances and current challenges in tumor immunology and immunotherapy. MOL THER. 15:1065-1071. DOI.
  • Magnusson MK; Henning P; Myhre S; Wikman M; Uil TG; Friedman M; Andersson KME; Hong SS; et al. (May 2007). Adenovirus 5 vector genetically re-targeted by an affibody molecule with specificity for tumor antigen HER2/neu. CANCER GENE THER. 14:468-479. DOI.
  • Bachellier P; Ayav A; Pai M; Weber JC; Rosso E; Jaeck D; Habib NA; Jiao LR. (Apr 2007). Laparoscopic liver resection assisted with radiofrequency. Am J Surg. 193:427-430. DOI.
  • Ayav A; Bachellier P; Habib NA; Pellicci R; Tierris J; Milicevic M; Jiao LR. (Feb 2007). Impact of radiofrequency assisted hepatectomy for reduction of transfusion requirements. Am J Surg. 193:143-148. DOI.
  • Ayav A; Jiao LR; Habib NA. (2007). Bloodless liver resection using radiofrequency energy. Dig Surg. 24:314-317. DOI.
  • Levicar N; Dimarakis I; Flores C; Tracey J; Gordon MY; Habib NA. (2007). Stem cells as a treatment for chronic liver disease and diabetes. Handb Exp Pharmacol. 243-262. DOI.
  • Ferko A; Lesko M; Subrt Z; Melichar B; Hoffman P; Dvorak P; Vacek Z; Liao LR; et al. (Dec 2006). A modified radiofrequency-assisted approach to right hemihepatectomy. EJSO-EUR J SURG ONC. 32:1209-1211. DOI.
  • Jiao LR; Tierris I; Ayav A; Milicevic M; Pellicci R; Navarra G; Habib NA. (Sep 2006). A new technique for spleen preservation with radiofrequency. Surgery. 140:464-466. DOI.
  • Jiao LR; Habib NA. (Aug 2006). Randomized clinical trial of the effects of abdominal drainage after elective hepatectomy using the crushing clamp method (Br J Surg 2006; 93: 422-426). Br J Surg. 93:1024-1025. DOI.
  • Gordon MY; Levicar N; Pai M; Bachellier P; Dimarakis I; Al-Allaf F; M'Hamdi H; Thalji T; et al. (Jul 2006). Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 24:1822-1830. DOI.
  • Habib NA; Gordon MY. (May 2006). Clinical applications of stem cell therapy - the pros and cons of stem cell sources. REGEN MED. 1:301-302. DOI.
  • Jiao LR; Navarra G; Weber JC; Havlic R; Nicholls JP; Habib NA. (2006). Radio frequency assisted liver resection: the Habib's technique. Adv Exp Med Biol. 574:31-37. DOI.
  • Ayav A; Navarra G; Habib NA; Jiao LR. (Nov 2005). New technique for liver resection using heat coagulative necrosis. Ann Surg. 242:751.
  • Bachellier P; Habib NA; Jiao LR; Weber JC. (Jan 2005). To the editor. WORLD J SURG. 29:116-116. DOI.
  • Jiao LR; Smadja C; Habib NA. (Oct 2004). Bloodless partial splenectomy - Reply. AM J SURG. 188:450-451. DOI.
  • Behranwala KA; Tisdall M; Habib NH; Canelo R. (Oct 2004). Spontaneous bilobar subcapsular hematoma of the liver while undergoing anticoagulation therapy: our experience and review of the literature. Int Surg. 89:212-216.
  • Madhusudan S; Tamir A; Bates N; Flanagan E; Gore ME; Barton DPJ; Harper P; Seckl M; et al. (1 May 2004). A Multicenter phase I gene therapy clinical trial involving intraperitoneal administration of E1A-lipid complex in patients with recurrent epithelial ovarian cancer overexpressing HER-2/neu oncogene. CLIN CANCER RES. 10:2986-2996.
  • Navarra G; Lorenzini C; Currò G; Basaglia E; Habib NH. (Jan 2004). Early results after radiofrequency-assisted liver resection. Tumori. 90:32-35.
  • Jiao LR; Havlik R; Nicholls J; Jensen SL; Habib NA. (2004). Suicide gene therapy in liver tumors. Methods Mol Med. 90:433-450.
  • Wales L; Tysome J; Menon R; Habib N; Navarra G. (Nov 2003). Caecal volvulus following laparoscopy-assisted sigmoid colectomy for sigmoid volvulus. Int J Colorectal Dis. 18:529-532. DOI.
  • Navarra G; Asopa V; Basaglia E; Jones M; Jiao LR; Habib NA. (May 2003). Mucous cystadenoma of the appendix: is it safe to remove it by a laparoscopic approach?. Surg Endosc. 17:833-834.
  • Khan SA; Carmichael PL; Taylor-Robinson SD; Habib N; Thomas HC. (Apr 2003). DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma. Gut. 52:586-591.
  • Zacharoulis D; Asopa V; Navarra G; Nicholls JP; Jensen SL; Habib NA. (Apr 2003). Hepatectomy using intraoperative ultrasound-guided radiofrequency ablation. Int Surg. 88:80-82.
  • Habib N; Jensen S. (2003). [Gene therapy in the treatment of colorectal cancer liver metastases]. Bull Acad Natl Med. 187:893-897.
  • Jiao LR; Habib NA. (Jan 2003). Experimental study of large-volume microwave ablation in the liver. BRIT J SURG. 90:122-122. DOI.
  • Hong ss; Habib NA; Franqueville L; Jensen S; Boulanger PA. (2003). Identification of adenovirus (Ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative Ad (Add/l1520) for treatment of liver tumors. Journal of Virology. 77:10366-10375.
  • Hong SS; Habib NA; Franqueville L; Jensen S; Boulanger PA. (2003). Identification of adenovirus (Ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative Ad (Addl1520) for treatment of liver tumors. Journal of Virology. 19, 77:10366-10375. Author weblink.
  • Weber JC; Navarra G; Habib NA; Bachellier P; Jaeck D. (2003). Laparoscopic radiofrequency-assisted liver resection. Surgical Endoscopy.
  • Navarra G; Aspoa V; Basaglia E; Jones M; Jiao LR; Habib NA. (2003). Mucous cystadenoma of the appendix. Surgical Endoscopy.
  • Serracino-Inglott F; Virlos IT; Habib NA; Williamson RC; Mathie RT. (20 Sep 2002). Adenosine preconditioning attenuates hepatic reperfusion injury in the rat by preventing the down-regulation of endothelial nitric oxide synthase. BMC Gastroenterol. 2:22.
  • Navarra G; Jiao LR; Weber JC; Nicholls JP; Jensen SL; Habib NA. (Jul 2002). A novel approach to gallbladder cancer in a Jehovah's Witness. Surg Endosc. 16:1109-1110. DOI.
  • Serracino-Inglott F; Habib NA; Mathie RT. (Jul 2002). Hepatic ischemia-reperfusion injury - Reply. AM J SURG. 184:84-85.
  • Spalding DRC; Navarra G; Zacharoulis D; Kirby S; Habib NA. (Jun 2002). New technique for liver resection using heat coagulative ablation. BRIT J SURG. 89:91-91.
  • Shen L; Ahuja N; Shen Y; Habib NA; Toyota M; Rashid A; Issa JP. (15 May 2002). DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst. 94:755-761.
  • Habib NA; Mitry RR; Sarraf CE; Jiao LR; Havlík R; Nicholls J; Jensen SL. (May 2002). Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus. Cancer Gene Ther. 9:414-420. DOI.
  • Havlik R; Jiao LR; Nicholls J; Jensen SL; Habib NA. (Apr 2002). Gene therapy for liver metastases. Semin Oncol. 29:202-208.
  • Habib N; Salama H; Abd El Latif Abu Median A; Isac Anis I; Abd Al Aziz RA; Sarraf C; Mitry R; Havlik R; et al. (Mar 2002). Clinical trial of E1B-deleted adenovirus (dl1520) gene therapy for hepatocellular carcinoma. Cancer Gene Ther. 9:254-259. DOI.
  • Navarra G; Spalding D; Zacharoulis D; Nicholls J; Kirby S; Costa I; Habib NA. (2002). Bloodless hepatectomy technique. HIPB. 4:95-97.
  • Navarra G; Spalding D; Zacharoulis D; Nicholls JP; Habib NA. (2002). Bloodless hepatectomy technique. 4:95-97.
  • Habib NA; Salama H; Median AA; Anis IL; Ahmed P; Sarraf CE; Mitry RR; Havlik R; et al. (Nov 2001). Randomised phase II trial of Ad E1B deleted adenovirus (DL1520) gene therapy versus ethanol injection for treatment of hepatocellular carcinoma. CANCER GENE THER. 8:918-918.
  • Yano N; Habib NA; Fadden KJ; Yamashita H; Mitry R; Jauregui H; Kane A; Endoh M; et al. (Aug 2001). Profiling the adult human liver transcriptome: analysis by cDNA array hybridization. J HEPATOL. 35:178-186.
  • Jiao LR; Inglott FS; Mathie RT; Habib NA. (Jul 2001). The effect of augmenting portal venous inflow on intrahepatic pressure and resistance in the isolated perfused porcine liver. Hepatogastroenterology. 48:1011-1014.
  • Havlík R; Kerkhoffs W; Jiao LR; Schumacher O; Reul H; Habib N. (May 2001). Intravascular micropump for augmented liver perfusion: first in vivo experience. Artif Organs. 25:392-394.
  • Zhao J; Wang H; Wei LX; Habib NA; Lu X; Wu MC; Guo YJ. (May 2001). The cytotoxic effect of E1B 55-kDa mutant adenovirus on human hepatocellular carcinoma cell lines. CANCER GENE THER. 8:333-341.
  • Usatoff V; Habib NA. (Mar 2001). Update of laser-induced thermotherapy for liver tumors. Hepatogastroenterology. 48:330-332.
  • Habib NA; Sarraf CE; Mitry RR; Havlík R; Nicholls J; Kelly M; Vernon CC; Gueret-Wardle D; et al. (10 Feb 2001). E1B-deleted adenovirus (dl1520) gene therapy for patients with primary and secondary liver tumors. Hum Gene Ther. 12:219-226. DOI.
  • Serracino-Inglott F; Habib NA; Mathie RT. (Feb 2001). Hepatic ischemia-reperfusion injury. Am J Surg. 181:160-166.
  • Habib NA. (Jan 2001). Liver cancer: Multitreatment modalities. HEPATO-GASTROENTEROL. 48:2-2.
  • Usatoff V; Isla AM; Habib NA. (Jan 2001). Liver resection in advanced hepatocellular carcinoma. Hepatogastroenterology. 48:46-50.
  • Yano N; Habib N; Fadden KJ; Yamashita H; Mitry RR; Jauregui H; Kane A; Endoh M; et al. (2001). Profiling the adult human liver transcriptome: Analysis by cDNA array hybridisation. J Hepatol. 2, 35:178-186.
  • Zhao J; Wang H; Wei L; Habib NA; Lu X; Wu M; Guo Y. (2001). The cytotoxic effect of E1B 55 k-DA mutant adenovirus on human hepatocellular carcinoma cell lines. Cancer Gene Therapy. 8:333-341.
  • Tullo A; D'Erchia AM; Honda K; Kelly MD; Habib NA; Saccone C; Sbisa E. (Sep 2000). New p53 mutations in hilar cholangiocarcinoma. EUR J CLIN INVEST. 30:798-803.
  • Schneider A; Rohr S; Kelly MD; Mitry R; Pignatelli M; Dore CJ; Gaub MP; Jaeck D; et al. (Aug 2000). Microsatellite instability and allelic imbalance in primary and secondary colorectal cancer. AUST NZ J SURG. 70:587-592.
  • Havlik R; Sbisà E; Tullo A; Kelly MD; Mitry RR; Jiao LR; Mansour MR; Honda K; et al. (Jul 2000). Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors. Hepatogastroenterology. 47:927-931.
  • Jiao LR; Havlik R; Habib NA. (Jun 2000). Short-term results of radiofrequency ablation in liver tumors - Reply. AM J SURG. 179:527-527.
  • Mitry RR; Sarraf CE; Havlík R; Habib NA. (Apr 2000). Detection of adenovirus and initiation of apoptosis in hepatocellular carcinoma cells after Ad-p53 treatment. Hepatology. 31:885-889. DOI.
  • Havlík R; Habib N. (2000). E1B-deleted adenovirus as therapeutic tool for patients with liver tumours. Acta Univ Palacki Olomuc Fac Med. 143:84.
  • Mitry RR; Mansour MR; Havlík R; Habib NA. (2000). Gene therapy for liver tumours. Adv Exp Med Biol. 465:193-205. DOI.
  • Tullo A; D'Erchia AM; Honda K; Mitry RR; Kelly MD; Habib NA; Saccone C; Sbisa E. (Nov 1999). Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters. CLIN CANCER RES. 5:3523-3528.
  • Jiao LR; Habib NA. (Sep 1999). Interstitial laser coagulation for hepatic tumours. BRIT J SURG. 86:1224-1224.
  • Hansen PD; Isla AM; Habib NA. (Sep 1999). Liver resection using total vascular exclusion, scalpel division of the parenchyma, and a simple compression technique for hemostasis and biliary control. J GASTROINTEST SURG. 3:537-542.
  • Habib NA; Hodgson HJ; Lemoine N; Pignatelli M. (10 Aug 1999). A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours. Hum Gene Ther. 10:2019-2034. DOI.
  • Stewart AK; Lassam NJ; Graham FL; Gauldi J; Wollenberg B; Habib NA. (10 Aug 1999). Human gene marker/therapy clinical protocols (complete updated listings). HUM GENE THER. 10:2037-2088.
  • Habib NA; Kelly MD; Zhao J; Miltry RR; Michail NE; Edward E; El-Masry R; Harsan M; et al. (Jul 1999). E1B-deleted adenovirus gene therapy for liver tumours. CANCER GENE THER. 6:389-389.
  • Habib NA; Mitry RR; Kelly MD; Havlik R; Jiao LR; Kiri A; Goldspink G. (Apr 1999). Albumin gene therapy for hepatic insufficiency. GUT. 44:A58-A58.
  • Kelly MD; Habib NA; Mitry RR; Lemoine N; Hodgson HJF; Pignatelli M. (Apr 1999). Gene replacement for liver tumours. GUT. 44:A49-A49.
  • Mitry RR; Zhao J; Mansour MR; Habib NA. (Apr 1999). In vivo effects of Ad-p53 on human hepatocellular carcinoma tumour size grown subcutaneously in nude mice. GUT. 44:A100-A100.
  • Havlik R; Mansour MR; Jiao LR; Kelly MD; Habib NA. (Apr 1999). Liver resection for hilar cholangiocarcinoma. GUT. 44:A62-A62.
  • Zhao J; Mitry RR; Guo Y; Lemoine N; Habib NA. (Apr 1999). p53 enhanced the antitumoral efficacy of E1B 55-Kilodalton mutant adenovirus on hepatocellular carcinoma cell line. GUT. 44:A87-A87.
  • Havlik R; Jiao LR; Mitry RR; Kelly MD; Usatoff V; Habib NA. (Apr 1999). Radiofrequency ablation therapy in liver tumors. GUT. 44:A62-A62.
  • Habib NA; Jiao L; Thodiyil P; Mitry R; Edward N; Edward E; El-Masry R; Dalla Serra G; et al. (Nov 1998). Gene therapy for patients with hepatocellular carcinoma. CANCER GENE THER. 5:S26-S26.
  • Al-Musawi D; Hansen P; Tanaka H; Isla A; Habib NA. (Jul 1998). Liver resection for colorectal metastases: results and prognostic factors. BRIT J CANCER. 78:152-152.
  • Honda K; Sbisà E; Tullo A; Papeo PA; Saccone C; Poole S; Pignatelli M; Mitry RR; et al. (Mar 1998). p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation. Br J Cancer. 77:776-782.
  • Badia JM; Ayton LC; Evans TJ; Carpenter AJ; Nawfal G; Kinderman H; Zografos G; Uemoto S; et al. (Mar 1998). Systemic cytokine response to hepatic resections under total vascular exclusion. Eur J Surg. 164:185-190. DOI.
  • Habib NA; Mitry RR; Sadri R. (1998). p53 and gene therapy for hepatocellular carcinoma. Adv Exp Med Biol. 451:499-504.
  • Zografos GN; Palmer S; Papastratis G; Habib NA. (Dec 1997). Aggressive surgical management of fibrolamellar hepatocellular carcinoma in puberty. Eur J Surg Oncol. 23:570-572.
  • Wu CG; Habib NA; Mitry RR; Reitsma PH; vanDeventer SJH; Chamuleau RAFM. (Nov 1997). Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. BRIT J CANCER. 76:1199-1204.
  • Mitry RR; Sarraf CE; Wu CG; Pignatelli M; Habib NA. (Oct 1997). Wild-type p53 induces apoptosis in Hep3B through up-regulation of bax expression. Lab Invest. 77:369-378.
  • Isla AM; Ferrara A; Badia JM; Holloway I; Tanaka H; Riaz A; Habib NA. (Sep 1997). Fibrolamellar hepatocellular carcinoma: results of partial liver resection. REV ESP ENFERM DIG. 89:703-705.
  • Martínez Isla A; Ferrara A; Badia JM; Holloway I; Tanaka H; Riaz A; Habib NA. (Sep 1997). Fibrolamellar hepatocellular carcinoma: results of partial liver resection. Rev Esp Enferm Dig. 89:699-705.
  • Habib NA. (Sep 1997). Gene therapy for liver tumours. CANCER GENE THER. 4:329-330.
  • Wu CG; Habib NA; Mitry RR; Reitsma PH; vanDeventer SJH; Chamuleau RAFM. (Jul 1997). Increased hepatic ferritin-H messenger RNA levels correlate with those of c-myc in human hepatocellular carcinoma. INT J ONCOL. 11:187-192.
  • Poole S; Batchelor WH; Ashton MD; Habib NA; Pignatelli M. (1997). Immunohistochemical expression of the E-cadherin-catenin complex in primary hepatocellular fibrolamellar and cholangiocarcinomas. J PATHOL. 181:A37-A37.
  • Tullo A; Papeo PA; DErchia AM; Honda K; Mitry RR; Ding SF; Saccone C; Habib NA; et al. (Jan 1997). Mutational pattern of p53 gene in patients with hepatocellular carcinoma. CANCER GENE THER. 4:71-71.
  • Habib NA. (Jan 1997). Preliminary results of intratumoural plasmid p53 injection in patients with localized hepatocellular carcinoma. CANCER GENE THER. 4:67-67.
  • Moussa ME; Sarraf CE; Uemoto S; Sawada H; Habib NA. (Nov 1996). Effect of total hepatic vascular exclusion during liver resection on hepatic ultrastructure. Liver Transpl Surg. 2:461-467.
  • Habib NA; Ding SF; el-Masry R; Mitry RR; Honda K; Michail NE; Dalla Serra G; Izzi G; et al. (1996). Preliminary report: the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detect Prev. 20:103-107.
  • Habib NA; Michail NE; Smith P. (1996). The use of hypothermia and circulatory arrest to control intraoperative bleeding from the inferior vena cava. Surg Today. 26:217-218.
  • Moussa ME; Bean AG; Habib NA. (Sep 1995). Repeated resection for malignant liver tumours. Ann R Coll Surg Engl. 77:364-368.
  • Uemoto S; Martin AJ; Fleming W; Habib NA. (Sep 1995). The use of transjugular intrahepatic portosystemic shunt and surgical portocaval H-shunt for the treatment of colorectal variceal bleeding. Hepatogastroenterology. 42:557-560.
  • Habib NA. (Mar 1995). Early mortality in 100 consecutive liver resections in 96 patients with benign and malignant liver tumours. Ann R Coll Surg Engl. 77:107-110.
  • Ding SF; Habib NA. (Feb 1995). Loss of heterozygosity in liver tumours. J Hepatol. 22:230-238.
  • Uemoto S; Fleming W; Keogh BE; Habib NA. (Jan 1995). Combined pulmonary tumour embolectomy and extended right hepatectomy with inferior vena cava resection for advanced hepatocellular carcinoma. Br J Surg. 82:127-128.
  • HABIB NA. (Jan 1995). LIVER RESECTION WITH TOTAL VASCULAR EXCLUSION FOR MALIGNANT-TUMORS - REPLY. BRIT J SURG. 82:139-139.
  • Habib NA; Cerný J; Danninger F. (Jul 1994). [Total vascular exclusion of the liver--an advance in hepatic surgery]. Rozhl Chir. 73:221-222.
  • Habib NA; Michail NE; Boyle T; Bean A. (Jul 1994). Resection of the inferior vena cava during hepatectomy for liver tumours. Br J Surg. 81:1023-1024.
  • Ding SF; Delhanty JD; Zografos G; Michail NE; Dooley JS; Habib NA. (Jun 1994). Chromosome allele loss in colorectal liver metastases and its association with clinical features. Br J Surg. 81:875-878.
  • Ding SF; Michail NE; Habib NA. (May 1994). Genetic changes in hepatoblastoma. J Hepatol. 20:672-675.
  • LI J; DING SF; HABIB NA; FERMOR BF; WOOD CB; GILMOUR RS. (1 May 1994). PARTIAL CHARACTERIZATION OF A CDNA FOR HUMAN STEAROYL-COA DESATURASE AND CHANGES IN ITS MESSENGER-RNA EXPRESSION IN SOME NORMAL AND MALIGNANT-TISSUES. INT J CANCER. 57:348-352.
  • JALLEH RP; SMITH PLC; HABIB NA. (Mar 1994). 2-STEP MESOATRIAL SHUNT IN BUDD-CHIARI SYNDROME. EUR J SURG. 160:185-186.
  • Jalleh RP; Smith PL; Habib NA. (Mar 1994). Two step mesoatrial shunt in Budd-Chiari syndrome. Case report. Eur J Surg. 160:185-186.
  • HABIB NA. (Feb 1994). ELECTIVE HEPATIC RESECTION FOR BENIGN AND MALIGNANT LIVER-DISEASE - EARLY RESULTS - REPLY. BRIT J SURG. 81:311-311.
  • Koh MK; Ahmad H; Watanapa P; Jalleh RP; Habib NA. (1994). Beware the anomalous portal vein. HPB Surg. 7:237-239.
  • DING SF; CARRILLO A; DOOLEY JS; DELHANTY JDA; BOWLES L; DALLASERRA G; WOOD CB; HABIB NA. (15 Nov 1993). MULTIPLE ALLELIC LOSSES IN SARCOMATOID LIVER-CARCINOMA. INT HEPATOL COMMUN. 1:295-301.
  • TARGARONA EM; ZOGRAFOS G; HABIB NA. (Nov 1993). LIVER RESECTION FOR RECURRENT HILAR CHOLANGIOCARCINOMA. BRIT J SURG. 80:1433-1433.
  • Targarona EM; Zografos G; Habib NA. (Nov 1993). Liver resection for recurrent hilar cholangiocarcinoma. Br J Surg. 80:1433.
  • Habib NA; Koh MK; Zografos G; Awad RW; Bottino G. (Aug 1993). Elective hepatic resection for benign and malignant liver disease: early results. Br J Surg. 80:1039-1041.
  • DING SF; DELHANTY JDA; CARRILLO A; SERRA GD; BOWLES L; DOOLEY JS; WOOD CB; HABIB NA. (Jun 1993). LACK OF DEMONSTRABLE CHROMOSOME ALLELE LOSS IN HEPATOCELLULAR ADENOMA. INT J ONCOL. 2:977-979.
  • DING SF; DELHANTY JDA; BOWLES L; DOOLEY JS; WOOD CB; HABIB NA. (May 1993). LOSS OF CONSTITUTIONAL HETEROZYGOSITY ON CHROMOSOME-5 AND CHROMOSOME-17 IN CHOLANGIOCARCINOMA. BRIT J CANCER. 67:1007-1010.
  • Ding SF; Delhanty JD; Bowles L; Dooley JS; Wood CB; Habib NA. (May 1993). Loss of constitutional heterozygosity on chromosomes 5 and 17 in cholangiocarcinoma. Br J Cancer. 67:1007-1010.
  • Ding SF; Jalleh RP; Dooley J; Wood CB; Habib NA. (Apr 1993). Chromosome 17 allele loss in hepatocellular carcinoma but not in synchronous liver adenoma. Eur J Surg Oncol. 19:195-197.
  • HABIB NA; HIGGS BD; MARWAN I; ELMASRY R; HELMI A; SAIFI R; ABBAS A; ABDELWOHAB F; et al. (Apr 1993). LIVING-RELATED LIVER-TRANSPLANTATION IN AFRICA. INT SURG. 78:121-123.
  • Ding SF; Delhanty JD; Bowles L; Dooley JS; Wood CB; Habib NA. (Feb 1993). Infrequent chromosome allele loss in fibrolamellar carcinoma. Br J Cancer. 67:244-246.
  • Kelly SB; Habib NA; Blumgart LH. (1993). Long-term survival in a patient following resection for carcinoma of the gallbladder and rectum. HPB Surg. 7:165-174.
  • Ding SF; Delhanty JD; Dooley JS; Bowles L; Wood CB; Habib NA. (1993). The putative tumor suppressor gene on chromosome 5q for hepatocellular carcinoma is distinct from the MCC and APC genes. Cancer Detect Prev. 17:405-409.
  • DING SF; JALLEH RP; WOOD CB; BOWLES L; DELHANTY JDA; DOOLEY J; HABIB NA. (Oct 1992). DIFFERENT DNA CHANGES IN PRIMARY AND RECURRENT HEPATOCELLULAR-CARCINOMA. GUT. 33:1433-1435.
  • Kelly SB; Cooper J; Llewellyn S; Khoo DE; Virjee J; Wood CB; Williamson RC; Habib NA. (Aug 1992). Iodostearic acid in the treatment of advanced gastrointestinal carcinoma. Eur J Surg Oncol. 18:357-361.
  • Watanapa P; Ahmad H; Williamson RC; Habib NA. (Aug 1992). Repeat hepatic resection for metachronous carcinoma of the liver. J R Coll Surg Edinb. 37:252-254.
  • DING SF; WONG K; DAVIDSON B; DOOLEY J; DHILLON AP; WOOD CB; HABIB NA. (Jul 1992). DIFFERENCES IN THE TUMOR DNA ANALYSIS OF A HEPATOCELLULAR-CARCINOMA AND A SYNCHRONOUS FIBROLAMELLAR VARIANT. INT J ONCOL. 1:191-193.
  • Swift RI; Gaer J; Worman C; Thomas M; Habib NA; Wood CB. (Jun 1992). In vitro sensitized autologous tumorocidal lymphocytes to colonic adenocarcinoma. Eur J Surg Oncol. 18:258-263.
  • DING SF; HABIB NA; DELHANTY JDA; BOWLES L; GRECO L; WOOD C; WILLIAMSON RCN; DOOLEY JS. (Jun 1992). LOSS OF HETEROZYGOSITY ON CHROMOSOME-1 AND CHROMOSOME-11 IN CARCINOMA OF THE PANCREAS. BRIT J CANCER. 65:809-812.
  • DING SF; HABIB NA; DELHANTY J; BOWLES L; WOOD C; WILLIAMSON RCN; DOOLEY J. (Mar 1992). ALLELE LOSS ON CHROMOSOME-1 AND CHROMOSOME-II IN CARCINOMA OF THE PANCREAS. GUT. 33:A428-A428.
  • Cheslyn-Curtis S; Emberton M; Ahmed H; Williamson RC; Habib NA. (Mar 1992). Bile duct injury following laparoscopic cholecystectomy. Br J Surg. 79:231-232.
  • DING SF; HABIB NA; DOOLEY JJ; WOOD C; BOWLES L; DELHANTY J. (Oct 1991). DIFFERENT PATTERN OF GENOMIC DNA LOSS IN COLORECTAL LIVER METASTASIS AND HEPATOCELLULAR-CARCINOMA. GUT. 32:A1249-A1249.
  • Khoo DE; Flaks B; Oztas H; Williamson RC; Habib NA. (Oct 1991). Effects of dietary fatty acids on the early stages of neoplastic induction in the rat pancreas. Changes in fatty acid composition and development of atypical acinar cell nodules. Int J Exp Pathol. 72:571-580.
  • Swift RI; Danpure HJ; Osman S; Gaer J; Tsikos C; Peters AM; Lavender JP; Tebbut S; et al. (22 Jun 1991). Imaging of metastatic colorectal cancer with tumour-activated killer lymphocytes. Lancet. 337:1511-1512.
  • DING SF; DOOLEY J; DELHANTY J; BOWLES L; WOOD C; HABIB NA. (May 1991). ALLELE LOSS OF CHROMOSOME-1, CHROMOSOME-5, AND CHROMOSOME-17 IN CHOLANGIOCARCINOMA. GUT. 32:A600-A600.
  • KHOO DE; FERMOR B; MILLER J; WOOD CB; APOSTOLOV K; BARKER W; WILLIAMSON RCN; HABIB NA. (Jan 1991). MANIPULATION OF BODY-FAT COMPOSITION WITH STERCULIC ACID CAN INHIBIT MAMMARY CARCINOMAS INVIVO. BRIT J CANCER. 63:97-101.
  • KELLY SB; MILLER J; WOOD CB; WILLIAMSON RCN; CHIR M; HABIB NA. (Dec 1990). ERYTHROCYTE STEARIC-ACID DESATURATION IN PATIENTS WITH COLORECTAL-CARCINOMA. DIS COLON RECTUM. 33:1026-1030.
  • Dawson PM; Habib NA; Fane S; Rees HC; Wood CB; Allen-Mersh TG. (Nov 1990). Association between extent of colonic mucosal sialomucin change and subsequent local recurrence after curative excision of primary colorectal cancer. Br J Surg. 77:1279-1283.
  • HABIB NA; FOO CL; ELMASRY R; GOULI O; COX S; SALEM R; TODD B; BENJAMIN IS. (May 1990). COMPLICATIONS OF CHOLECYSTECTOMY IN DISTRICT GENERAL HOSPITALS. BRIT J CLIN PRACT. 44:189-&.
  • KHOO DE; FLAKS B; WOOD CB; WILLIAMSSON RCN; HABIB NA. (May 1990). DIETARY STEARIC AND OLEIC ACIDS IN EXPERIMENTAL PANCREATIC NEOPLASIA. GUT. 31:A620-A620.
  • Gleeson RP; Ayub M; Wright JT; Wood CB; Habib NA; Soutter WP; Sullivan MH; White JO. (Apr 1990). Fatty acid control of growth of human cervical and endometrial cancer cells. Br J Cancer. 61:500-503.
  • ROTHNIE ND; HUICI SU; ROONEY N; WOOD CB; WILLIAMSON RCN; BARTOLO DCC; HABIB NA. (May 1989). DIFFERENCE IN ANTIGENIC EXPRESSION BETWEEN ASCENDING AND DESCENDING COLON. GUT. 30:A738-A739.
  • ROTHNIE ND; HUICI SU; ROONEY N; WOOD CB; WILLIAMSON RCN; BARTOLO DCC; HABIB NA. (May 1989). IMMUNOHISTOCHEMICAL STUDY OF A TUMOR ASSOCIATED ANTIGEN RECOGNIZED BY MONOCLONAL-ANTIBODY C466. GUT. 30:A713-A713.
  • KELLY SB; HABIB NA; HERSHMAN MJ. (Feb 1989). CARCINOMA ASSOCIATED ANTIGEN IN THE DETECTION OF GASTROINTESTINAL CARCINOMAS. BRIT J CANCER. 59:319-319.
  • DAWSON PM; REES HC; HABIB NA; ALLENMERSH TG; WOOD CB. (Dec 1988). EXTENT OF SIALOMUCIN PREDICTS PATIENTS AT RISK OF LOCAL RECURRENCE OF COLORECTAL-CANCER. BRIT J SURG. 75:1247-1247.
  • DAWSON PM; REES HC; HABIB NA; ALLENMERSH TG; WOOD CB. (Oct 1988). THE PRESENCE OF SIALOMUCIN AT THE RESECTION MARGIN IDENTIFIES PATIENTS AT RISK OF LOCAL RECURRENCE OF COLORECTAL-CANCER. GUT. 29:A1495-A1495.
  • LUCAROTTI M; KELLY S; HABIB NA; LEAPER DJ; HERSHMAN M; WILLIAMSON RCN; WOOD C. (Aug 1988). THE CLINICAL USE OF CA19-9 IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN AND MALIGNANT DISEASE OF THE GASTROINTESTINAL-TRACT. BRIT J CANCER. 58:253-253.
  • LUCAROTTI M; KELLY S; HABIB NA; LEAPER DJ; HERSHMAN M; WILLIAMSON RCN; WOOD C. (Aug 1988). THE COMBINED USE OF THE TUMOR-ANTIGENS CEA, CA19-9 AND CA50 IN DISCRIMINATION OF ESOPHAGOGASTRIC CARCINOMAS. BRIT J CANCER. 58:252-252.
  • HERSHMAN MJ; HABIB NA; APOSTOLOV K; WOOD CB. (Sep 1987). ERYTHROCYTE DESATURATION AS A MARKER OF HUMAN MALIGNANCY. CLIN RES. 35:A817-A817.
  • WHITE JO; HERSCHMAN MJ; PARMAR G; PHILIPSON KA; ELDER MG; HABIB NA; WOOD CB. (Jul 1987). ACTIVATED ESTROGEN-RECEPTOR IN HUMAN-BREAST CANCER - CLINICAL AND BIOCHEMICAL CORRELATES. BRIT J SURG. 74:588-590.
  • Dawson PM; Habib NA; Wood CB. (Jul 1987). Influence of sialomucins at the resection margin on survival of patients with colorectal cancer. Int Surg. 72:129-130.
  • DAWSON PM; HABIB NA; REES HC; WILLIAMSON RCN; WOOD CB. (May 1987). INFLUENCE OF SIALOMUCIN AT THE RESECTION MARGIN ON LOCAL TUMOR RECURRENCE AND SURVIVAL OF PATIENTS WITH COLORECTAL-CANCER - A MULTIVARIATE-ANALYSIS. BRIT J SURG. 74:366-369.
  • DAWSON PM; HABIB NA; REES HC; WOOD CB. (Mar 1987). MUCOSAL FIELD CHANGE IN COLORECTAL-CANCER. AM J SURG. 153:281-283.
  • EMBLETON MJ; HABIB NA; GARNETT MC; WOOD C. (15 Dec 1986). UNSUITABILITY OF MONOCLONAL-ANTIBODIES TO ONCOGENE PROTEINS FOR ANTITUMOR DRUG-TARGETING. INT J CANCER. 38:821-827.
  • DHOKIA B; PECTASIDES D; SELF C; HABIB NA; HERSHMAN M; WOOD CB; MUNRO AJ; EPENETOS AA. (Dec 1986). A LOW PH ENZYME LINKED IMMUNOASSAY USING 2 MONOCLONAL-ANTIBODIES FOR THE SEROLOGICAL DETECTION AND MONITORING OF BREAST-CANCER. BRIT J CANCER. 54:885-889.
  • DHOKIA B; COURTENAYLUCK N; PECTASIDES D; TAYLORPAPADIMITRIOU J; SELF C; HABIB NA; HERSHMAN M; WOOD CB; et al. (Sep 1986). SEROLOGICAL MONITORING OF BREAST-CANCER BY A LOW PH ELISA METHOD. BRIT J CANCER. 54:543-543.
  • HABIB NA; HERSHMAN MJ; SMADJA C; WOOD CB. (Sep 1986). THE USE OF CA-50 RADIOIMMUNOASSAY INHIBITION TEST IN THE DIFFERENTIAL-DIAGNOSIS OF BENIGN AND MALIGNANT LIVER-DISEASES. BRIT J SURG. 73:758-759.
  • HABIB NA; DAWSON PM; BRADFIELD JWB; WILLIAMSON RCN; WOOD CB. (30 Aug 1986). SIALOMUCINS AT RESECTION MARGIN AND LIKELIHOOD OF RECURRENCE IN COLORECTAL-CARCINOMA. BRIT MED J. 293:521-523.
  • HABIB NA; WOOD CB. (Jul 1986). THE EXPRESSION OF RAS ONCOGENE IN NORMAL AND PATHOLOGICAL LIVER-DISEASE. INT SURG. 71:182-183.
  • HABIB NA; DAWSON PM; KRAUSZ T; BLOUNT MA; KERSTEN D; WOOD CB. (Jan 1986). A STUDY OF HISTOCHEMICAL-CHANGES IN MUCUS FROM PATIENTS WITH ULCERATIVE-COLITIS, CROHNS-DISEASE, AND DIVERTICULAR-DISEASE OF THE COLON. DIS COLON RECTUM. 29:15-17.
  • Dhokia B; Pectasides D; Epenetos AA; Sikora K; Habib NA; Hershman M; Wood CB. (Jan 1986). Serum levels of c-myc and c-ras oncogene products in normal subjects and in patients with neoplastic and non neoplastic conditions. Int J Biol Markers. 1:29-32.
  • HABIB NA; HERSHMAN MJ; PAPP L; SWIFT I; WILLIAMSON RCN; WOOD CB. (1986). THE DETECTION OF COLORECTAL CARCINOMAS WITH THE USE OF CA-50 RADIOIMMUNOASSAY INHIBITION TEST. INT J COLORECTAL DIS. 1:186-187.
  • NIMAN HL; THOMPSON AMH; YU A; MARKMAN M; WILLEMS JJ; HERWIG KR; HABIB NA; WOOD CB; et al. (1985). ANTI-PEPTIDE ANTIBODIES DETECT ONCOGENE-RELATED PROTEINS IN URINE. P NATL ACAD SCI USA. 82:7924-7928.
  • HABIB NA; SMADJA C; DAWSON P; WOOD CB. (1985). HISTOCHEMICAL-CHANGES IN MUCUS FROM PATIENTS WITH BENIGN AND MALIGNANT PATHOLOGICAL CONDITIONS OF THE COLON AND RECTUM. GASTROEN CLIN BIOL. 9:491-494.
  • WOOD CB; HABIB NA; THOMPSON A; BRADPIECE H; SMADJA C; HERSHMAN M; BARKER W; APOSTOLOV K. (1985). INCREASE OF OLEIC-ACID IN ERYTHROCYTES ASSOCIATED WITH MALIGNANCIES. BRIT MED J. 291:163-165.
  • HABIB NA; WOOD CB; APOSTOLOV K. (1985). INCREASE OF OLEIC-ACID IN ERYTHROCYTES ASSOCIATED WITH MALIGNANCIES. BRIT MED J. 291:972-972.
  • WOOD CB; HABIB NA; APOSTOLOV K; THOMPSON A; BARKER W; HERSHMAN M; BLUMGART LH. (1985). REDUCTION IN THE STEARIC TO OLEIC-ACID RATIO IN HUMAN-MALIGNANT LIVER NEOPLASMS. EUR J SURG ONCOL. 11:347-348.
  • WOOD CB; HABIB NA; APOSTOLOV K; KERSTEN D; BARKER W; SMADJA C; THOMPSON A; BLOUNT M. (1985). REDUCTION IN THE STEARIC TO OLEIC-ACID RATIO IN THE CIRCULATING RED BLOOD-CELLS - A POSSIBLE TUMOR-MARKER IN SOLID HUMAN NEOPLASMS. EUR J SURG ONCOL. 11:167-169.
  • HABIB NA; DAWSON PM; BLOUNT MA; COX S; KRAUSZ T; WOOD CB. (1985). STUDY OF THE HISTOCHEMICAL-CHANGES IN MUCUS FROM NORMAL AND TUMOR-BEARING MUCOSA IN PATIENTS WITH COLORECTAL-CANCER. EUR J SURG ONCOL. 11:243-245.
  • WOOD CB; DAWSON PM; HABIB NA. (1985). THE SIALOMUCIN CONTENT OF COLONIC RESECTION MARGINS. DIS COLON RECTUM. 28:260-261.
  • MCPHERSON GAD; BENJAMIN IS; HABIB NA; BOWLEY NB; BLUMGART LH. (1982). PERCUTANEOUS TRANS-HEPATIC DRAINAGE IN OBSTRUCTIVE-JAUNDICE - ADVANTAGES AND PROBLEMS. BRIT J SURG. 69:261-264.

Books

  • Habib NA. Habib N (ed); Gordon M (ed); Levicar N (ed); Jiao L (ed); Thomas-Black G (ed). 4. Stem Cell Repair and Regeneration. Imperial College Press (2005).
  • Habib NA. Habib NA (ed). Multi-treatment Modalities of Liver Tumours. Kluwer Academic / Plenum Publishers, New York, USA (2002).

Chapters in books

  • Habib N; Canelo R. Liver and biliary tree. In Clinical Surgery 2nd Edition. Henry MM (ed); Thompson JN (ed). Elsevier Saunders, London, UK (2005).
  • Havlik R; Usatoff V; Serracino-Inglott F; Athanassiou M; Serracino-Inglott K; Abo-El-Nazar E; Nicholls JP; Habib NA. Intra-operative radiofrequency heat ablation for hepatic tumours. In Multi-treatment Modalities of Liver Tumours. 167-177. Habib NA (ed). Kluwer Academic / Plenum Publishers, New York, USA (2002).
  • Usatoff V; Hansen P; Al Musawi D; Havlik R; Dore C; Wright A; Habib NA. Liver resection for colorectal liver metastases: Results and prognostic factors. In Multi-treatment Modalities of Liver Tumours. 33-41. Habib NA (ed). Kluwer Academic / Plenum Publishers, New York, USA (2002).
  • Usatoff V; Isla AM; Habib NA. Liver resection in advanced hepatocellular carcinoma. In Multi-treatment Modalities of Liver Tumours. 11-19. Habib NA (ed). Kluwer Academic / Plenum Publishers, New York, USA (2002).
  • Usatoff V; Habib NA. Update of laser induced thermotherapy for liver tumours. In Multi-treatment Modalities of Liver Tumours. 189-195. Habib NA (ed). Kluwer Academic / Plenum Publishers, New York, USA (2002).
  • Habib N; Scott-Coombes D. Liver and biliary tree. In Clinical Surgery. 273-292. Henry MM (ed); Thompson JN (ed). WB Saunders (2001).

Conferences

  • Pai M; Helmy S; Jiao LR; Levicar N; Tait P; Marley SB; Thillainayagam A; Bansi D; et al. Clinical application of adult bone marrow-derived stem cell progenitors. Combined Meeting of the 17th European-Society-of-Gene-and-Cell-Therapy/16th German-Society-for-Gene-Therapy/4th German-Society-for-Stem-Cell-Research, 21 Nov 2009 - 25 Nov 2009. 20:1367-1367. MARY ANN LIEBERT INC (Nov 2009).
  • Khan SA; Taylor-Robinson SD; Carmichael PL; Habib N; Lemoine N; Thomas HC. Novel p53 mutations but lack of a mutational fingerprint in human intrahepatic cholangiocarcinoma. Annual meeting of the British-Society-of-Gastroenterology, 23 Mar 2003 - 26 Mar 2003. 52:A32-A32. BRITISH MED JOURNAL PUBL GROUP (Apr 2003).
  • Magnusson MK; Ohno I; Kraaij R; van Weerden WM; Myhre S; Habib NA; Kasahara N; Lindholm L. Transductionally retargeted Adenovirus vectors for tumor treatment. 16th Annual Congress of the European-Society-of-Gene-and-Cell-Therapy, 13 Nov 2008 - 16 Nov 2008. 19:1077-1077. MARY ANN LIEBERT INC (Oct 2008).
  • Moussa ME; Isla AM; Sarraf CE; Uemoto S; Sawada H; Habib NA. Effect of total vascular exclusion during liver resection on hepatic ultrastructure. 2nd World Congress of the International-Hepato-Pancreato-Biliary-Association, 2 Jun 1996 - 6 Jun 1996. 405-409. MONDUZZI EDITORE (1996).
  • Ayav A; Pellici A; Tierris J; Milicevic M; Nicholls JP; Harris D; Costa I; Jiao LR; et al. Radiofrequency assisted hepatectomy. 40th Congress of the European-Society-for-Surgical-Research, 25 May 2005 - 28 May 2005. 25-26. MEDIMOND S R L (2005).
  • Leviar N; Pai M; Habib NA; Tait P; Jiao LR; Marley SB; Davis J; Dazzi E; et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34(+) cells in patients with chronic. International Congress on Stem Cells: What Future for Therapy?. 41:115-125. (Feb 2008).
  • Gordon MY; Levicar N; Al-Allaf F; Dimarakis I; Thalji T; Welsh J; Alexandre E; Habib NA. A subpopulation of CD34+stem cells with potential to repopulate tissue. 34th Annual Meeting of the International-Society-for-Experimental-Hematology, 30 Jul 2005 - 2 Aug 2005. 33:109-110. ELSEVIER SCIENCE INC (Jul 2005).
  • Habib NA. Gene therapy for liver cancer. Meeting of the International-Society-for-Cancer-Gene-Therapy, 20 Feb 2004 - 22 Feb 2004. 11:842-842. NATURE PUBLISHING GROUP (Dec 2004).
  • Habib NA; Jiao LR; Navarra G; Basaglia E; Canelo R; Thillainayagam AV. A paradigm shift towards bloodless liver surgery: Radiofrequency assisted liver resection optimises safety and minimises blood loss and ICU admission. Annual Meeting of the British-Society-of-Gastroenterology, 21 Mar 2004 - 24 Mar 2004. 53:A87-A87. B M J PUBLISHING GROUP (Apr 2004).
  • Jiao LR; Navarra G; Canelo R; Wasan HS; Thillainayagam AV; Habib NA. Liver metastases from colorectal cancer (CRC) considered unsuitable for resection with curative intent: Intra-operative radiofrequency ablation (RFA) is associated with favourable long term survival. Annual Meeting of the British-Society-of-Gastroenterology, 21 Mar 2004 - 24 Mar 2004. 53:A14-A14. B M J PUBLISHING GROUP (Apr 2004).
  • Navarra G; Basaglia E; Habib NA. Radiofrequency-assisted liver resection. Annual Meeting of the Association-of-Upper-Gastrointestinal-Surgeons-of-Great-Britain-and-Ireland, 26 Sep 2002 - 27 Sep 2002. 90:377-378. JOHN WILEY & SONS LTD (Mar 2003).
  • Habib NA; El-Masry R; Mitry RR; Michail NE; Abdel-Ghaffar Y; Moenis A. Preliminary results of Intratumoral plasmid p53 injection in patients with localised hepatocellular carcinoma. 8th World Congress of the International Gastro-Surgical Club. 375-387. (1998).

Patents

  • Improvements in liver surgery. Patent number: US6694984B2 (USA). Ltd ICI. Filed: 27 Mar 2002. Published: 24 Feb 2004.
  • Applicator for microwave radiation treatment. Patent number: WO00/07666A1 (Europe, USA, Japan (pending), Canada (pending)). Sangster A. Filed: 17 Feb 2000. Published: 2004.
  • Monitoring treatment using implantable telemetric sensors. Patent number: WO0004945A3 (Europe, USA, Japan (pending)). Sangster A. Filed: 21 Jun 2001. Published: 2004.
  • Treatment using implantable devices. Patent number: WO0004946A3 (Europe, USA, Japan (pending)). Sangster A. Filed: 17 May 2001. Published: 2004.
  • Surgical Resection device. Application: GB0322766.7. Limited E.
Social Bookmarking:
Delicious
Digg